Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Non-Compliance with Hormonal Therapy for Breast Cancer and Risk of Death

Posted Sep 06 2010 9:40pm
 

 

Weekly Health Update:

Non-Compliance with Hormonal Therapy
for Breast Cancer and Risk of Death


"A critical weekly review of important new research findings for health-conscious readers..."

 

By, Robert A. Wascher, MD, FACS

 

Photo of Dr. Wascher

Updated:  09/5/2010

The information in this column is intended for informational purposes only, and does not constitute medical advice or recommendations by the author.  Please consult with your physician before making any lifestyle or medication changes, or if you have any other concerns regarding your health.


Welcome to Weekly Health Update


“A critical weekly review of important new research findings for health-conscious readers”


 

NON-COMPLIANCE WITH HORMONAL THERAPY
FOR BREAST CANCER AND RISK OF DEATH

 

The management of breast cancer today bears little resemblance to the way that we managed this most common cancer among women when I entered medical school in the early 1980s. Back then, both early-stage and advanced breast cancers were managed with a standard “one-size-fits-all” approach that included removal of the entire breast (mastectomy) and most of the lymph nodes in the armpit area (axillary lymph node dissection). Twenty-five years ago, most women with breast cancer also received chemotherapy, while “hormonal therapy” for many premenopausal women with breast cancer consisted of the surgical removal of both ovaries (oopherectomy). 

 

In 2010, 85 to 90 percent of women are eligible to undergo breast-conserving surgery (“lumpectomy”). Radical removal of the armpit lymph nodes has also become unnecessary for the majority of women with newly diagnosed breast cancer, as approximately two-thirds of women will be found to have normal armpit lymph nodes using a high-tech lymph node mapping procedure known as sentinel lymph node biopsy. (Sentinel lymph node biopsy is associated with one-tenth the incidence of the risks associated with more radical lymph node dissections.) Using a recently validated genetic test (Oncotype DX), many women with early-stage, favorable breast cancers can also safely choose to avoid chemotherapy, based upon the results of individualized “molecular” testing of their breast tumors. 

 

Instead of undergoing surgery to remove their ovaries, premenopausal women with hormone-sensitive breast cancers can now opt to take one of several different hormone-blocking medications (selective estrogen receptor modulators, or “SERMs”) for 5 years, to further reduce their risk of developing either a recurrence of their breast cancer or a new breast cancer. For postmenopausal women with hormone-sensitive cancers, a different class of hormone blocking medications, the aromatase inhibitors (“AIs”), are often prescribed, also for 5 years. These medications have been shown to reduce the risk of both recurrent breast cancer and new breast cancers by as much as 50 percent, and so they have become powerful clinical tools in our breast cancer prevention and treatment armamentarium. However, as with almost all medications, SERMs and AIs are associated with some rather significant side effects. In the case of SERMs, these side effects can include bone pain, hot flashes, nausea, mood swings, decreased libido, and constipation, among others. Tamoxifen, the most commonly prescribed SERM, is also associated with a small but significant increase in the risk of uterine cancer. (Raloxifene, the newest SERM to be approved for breast cancer prevention and treatment, appears not to significantly increase the risk of uterine cancer.) Both of these SERMS are also associated with an increased risk of blood clots in the body, as well. On the other hand, in addition to their potent ability to reduce the risk of both recurrent and new breast cancers, tamoxifen and raloxifene also decrease the risk of osteoporosis and osteoporosis-related bone fractures.

 

AIs are also associated with significant side effects in some patients, including hot flashes, bone and joint pain, mood changes, rash, headache, insomnia, and a small but significant increase in the risk of osteoporosis and osteoporosis-related bone fractures, among other symptoms and complications.

 

In view of the side effects profiles of SERMs and AIs, it is not surprising that patient compliance with these medications is an ongoing problem in the management of breast cancer (and, especially, among premenopausal women). A newly published clinical research study in the journal Breast Cancer Research & Treatment reveals just how serious the issue of patient compliance with hormonal therapy is among breast cancer patients, as well as the significant impact of such noncompliance on the subsequent risk of death.

 

In this clinical study, performed by my Northern California Kaiser Permanente colleagues, 8,769 women diagnosed with hormone-sensitive breast cancer between 1996 and 2007 were evaluated. One of the most powerful clinical assets of Kaiser Permanente is its comprehensive electronic health records system (“Health Connect”), which allows any Kaiser Permanente health care provider to access any individual patient’s detailed medical history, including diagnoses, past and current treatments (including surgeries and medications), lab results, radiology results, and other important clinical information. This rich source of clinical information not only improves the quality and efficiency of care provided to patients, but it also serves as a powerful tool to conduct meaningful clinical research on large numbers of patients in an effort to further improve the delivery of high-quality health care. (Indeed, Kaiser Permanente’s computerized medical records system is often held up as an example of what the future of electronic medical records should look like in the United States.)

 

The results of this study revealed the true potential costs of noncompliance with hormonal therapy among patients diagnosed with relatively early-stage hormone-sensitive breast cancers. Among the nearly 9,000 women who filled at least an initial prescription for their breast cancer hormonal therapy medications, 31 percent subsequently discontinued their SERMs or AIs, and an additional 28 percent continued with hormonal therapy, but were not fully compliant in taking their SERMs or AIs. (This combined 59 percent incidence of overall noncompliance is consistent with the 50 to 60 percent incidence of noncompliance with hormonal therapy that has been identified in previous clinical research studies.)

 

During an average follow-up period of 4.4 years, 831 of these 8,769 patients died. Based upon the observed survival data collected in this study, the women who were compliant with their SERMs or AIs had a statistically predicted 10-year survival rate of 81 percent, while the women who prematurely discontinued their hormonal therapy had a predicted 10-year survival rate of 74 percent. (The women who continued with their hormonal therapy, but who were not compliant with their daily doses, were projected to have an intermediate 10-year survival rate of 78 percent.) 

 

In the final analysis of their data, the authors of this study found that early discontinuation of hormonal therapy or continuing with hormonal therapy in a noncompliant manner were associated with a significant reduction in survival among patients with hormone-sensitive breast cancers.

 

The results of this study say two important things, in my mind. The first is that SERMs and AIs significantly reduce the risk of death in patients with hormone-sensitive breast cancer (as has already clearly been shown by multiple prospective, randomized, blinded, placebo-controlled clinical research studies). As with all medications, discontinuing hormonal therapies prematurely, or taking these important breast cancer medications in a haphazard manner, deprives breast cancer patients of the full potential benefits of SERMs and AIs. The second important observation to be derived from this study is that we need to continue to search for new hormonal therapies with improved side effect profiles, to encourage better patient compliance with this important aspect of breast cancer prevention and treatment.

 

If you are a breast cancer survivor who has been prescribed hormonal therapy (or a woman who is at very high risk of developing breast cancer, and who been prescribed a SERM or AI for breast cancer prevention purposes), then you should make every effort to work together with your Oncologist to help you to remain compliant with your SERM or AI prescription, including the aggressive management of any unpleasant treatment side effects that you might be experiencing.

 

To learn more about an evidence-based approach to breast cancer prevention, watch for the publication of my new landmark book, “ A Cancer Prevention Guide for the Human Race,” in September of this year.


I and the staff of Weekly Health Update would again like to take this opportunity to thank the more than 100,000 health-conscious people, from around the world, who visit our premier global health information website every month. As always, we enjoy receiving your stimulating feedback and questions, and I will continue to try and personally answer as many of your inquiries as I possibly can.


Disclaimer:  As always, my advice to readers is to seek the advice of your physicianbeforemaking any significant changes in medications, diet, or level of physical activity


Dr. Wascher is an oncologic surgeon, professor of surgery, cancer researcher, oncology consultant, and a widely published author


For a different perspective on Dr. Wascher, please click on the following YouTube link: 

Texas Blues Jam


 

Publication Date: September 2010

 

Dr. Wascher

Click above image for TV-6 interview of Dr. Wascher

(This video may take a few moments to load on your computer)

 


Click for TV36 Interview with Dr. Wascher

Click above image for TV36 interview of Dr. Wascher

 





Send your feedback to Dr. Wascher at: 

rwascher@doctorwascher.net


Dr. Wascher's Biography


Links to Other Health & Wellness Sites



 
Bookmark and Share
 


Copyright 2007 - 2010

 

Robert A. Wascher, MD, FACS

 

All rights reserved



Dr. Wascher's Archives:

8-29-2010:   New Treatment for Irritable Bowel Syndrome (IBS)

8-22-2010:  Lactoferrin Reduces Abdominal (Visceral) Obesity

8-15-2010:  Blueberries, Obesity, Diabetes and Metabolic Syndrome

8-8-2010:   High LDL Cholesterol in Young Adults and Heart Disease Risk in Middle Age

8-1-2010:      Physician Error

7-25-2010:   Obesity and Cancer Risk

7-18-2010:  Vitamin D Reduces Risk of Cognitive Decline & Dementia

7-11-2010:  All Forms of Hormone Replacement Therapy (HRT) Increase Breast Cancer Risk

7-4-2010:   Irritable Bowel Syndrome: Cause Discovered?

6-27-2010:  Soy, Curcumin & Prostate Cancer Risk

6-20-2010:  Green Tea Epicatechin Reduces Heart Damage & CHF

6-13-2010:  Diacylglycerol (Diglyceride) Oil Reduces Obesity

6-6-2010:   Important New Advance in the Breast Cancer Treatment: Intraoperative Radiation Therapy

5-30-2010:  Medical Research Studies & “Spin”

5-23-2010:  Soy & Curcumin Reduce Prostate-Specific Antigen (PSA)

5-16-2010:  Coffee & the Risk of Death from Heart Disease & Cancer

5-9-2010:     Soy Foods & Stomach Cancer Risk

5-2-2010:    Chemotherapy for Breast Cancer & Memory Loss

4-25-2010:    Smoking, Teenagers & Tobacco Company Advertising

4-18-2010:    Coffee Improves HDL Cholesterol Levels

4-11-2010:   Cruciferous Vegetables, Soy & Breast Cancer Risk

4-4-2010:     Avodart (Dutasteride) & Prostate Cancer Prevention

3-28-2010:   Aspirin & Breast Cancer Survival

3-21-2010:   Obesity, Alcohol & Liver Disease

3-14-2010:   Nuts, Diet & Obesity

3-7-2010:      Walnuts, Cholesterol, LDL & Triglycerides

2-28-2010:   Soy Isoflavones & Recurrent Prostate Cancer

2-21-2010:   Testosterone Supplements in Frail Elderly Men

2-14-2010:   Pancreatic Cancer Risk, Sodas & Juice

2-7-2010:      Vitamin D, Cardiovascular Disease & Death

1-31-2010:   Concord Grape Juice Improves Memory

1-24-2010:   Mozart, Music, Babies & Health

1-17-2010:   Breast Cancer, Physical Therapy & Lymphedema

1-10-2010:   Prevention of Surgical Site Infections (SSIs) after Surgery

1-3-2010:     Ginkgo Biloba, Memory & Cognitive Health

12-20-2009:  CT Scans & Cancer Risk

12-13-2009:  Soy Isoflavones Decrease Breast Cancer Recurrence Risk

12-6-2009:   Salt (Sodium) Intake, Stroke & Cardiovascular Disease

11-29-2009:  Exercise & Prostate Cancer Risk

11-22-2009:  Genistein (Soy Isoflavone) & Prostate Cancer

11-15-2009:  Breast Cancer Treatment & Chronic Pain

1-8-2009:      Vitamin D & Breast Cancer Risk

11-1-2009:   Exercise & Prostate Cancer Risk

10-25-2009:  HPV Virus & Risk of Breast Cancer

10-18-2009:  Post-Cholecystectomy Syndrome (Symptoms after Gallbladder Surgery)

10-11-2009: Vitamin D & Falls in the Elderly

10-4-2009:    Surgery, NSQIP, Complications & Death

9-27-2009     Stress, Heart Disease, Exercise & Death

9-20-2009:    Vitamin D & Colorectal Cancer Survival

9-13-2009:    H1N1 Swine Flu Update

9-7-2009:      Green Tea, Aging & Lifespan

8-30-2009:    Irritable Bowel Syndrome (IBS), Diet & Fiber

8-23-2009:   Update on Prostate Cancer and Cryotherapy

8-16-2009:    Exercise Improves Lymphedema Symptoms in Breast Cancer Survivors

8-9-2009:    Breast Cancer Recurrence, Death & Vitamin D

8-2-2009:    Honesty, Dishonesty & Brain Function

7-26-2009:    Coronary Artery CT Scans & Cancer Risk

7-19-2009:    Hormone Replacement Therapy (HRT) & Ovarian Cancer

7-12-2009:    Breast Cancer & Metformin (Glucophage)

7-5-2009:     Prostate Cancer & Green Tea

6-28-2009:    Air Pollution & the Risk of Deep Venous Thrombosis (DVT)

6-21-2009:    Red Yeast Rice, Statins & Cholesterol

6-14-2009:    Bone Marrow Stem Cell Transplant & Congestive Heart Failure (CHF)

6-7-2009:     Diet, Soy & Breast Cancer Risk

5-31-2009:    Diet and Prostate Cancer Risk

5-24-2009:    Diabetes, Glucose Control & Death

5-17-2009:    Drug Company Marketing & Physician Prescribing Bias

5-10-2009:    Hemorrhoids & Surgery

5-3-2009:      Statin Drugs & Blood Clots (Thromboembolism)

4-26-2009:    Are We Really Losing the War on Cancer?

4-19-2009:     Exercise in Middle Age & Risk of Death

4-12-2009:    Can Chronic Stress Harm Your Heart?

4-5-2009:      Does PSA Testing for Prostate Cancer Save Lives?

3-22-2009:    CABG Surgery vs. PCI in Diabetics with Coronary Artery Disease; Sweetened Beverages and Coronary Artery Disease

3-15-2009:    Depression, Stress, Anger & Heart Disease

3-8-2009:     Coronary Artery Disease: CABG vs. Stents?; Swimming Lessons & Drowning Risk in Children

3-1-2009:     Aspirin & Colorectal Cancer Prevention; Fish Oil & Respiratory Infections in Children

2-22-2009:  Health Differences Between Americans & Europeans; Lycopene & Prostate Cancer

2-15-2009:  Statin Drugs & Death Rates; Physical Activity, Breast Cancer & Sex Hormones

2-8-2009:    Hormone Replacement Therapy (HRT) & Breast Cancer; Stool DNA Testing & Cancer of the Colon & Rectum

2-1-2009:   Obesity and the Complications of Diverticulosis (Diverticulitis & Bleeding); Obesity, Weight Loss & Urinary Incontinence

1-25-2009:  Prostate Cancer, Fatigue & Exercise; Does your Surgeon “Warm-up” Before Surgery?

1-18-2009:  Cancer and Vitamins; Teenagers, MySpace and Risky Behaviors

1-11-2009:  Exercise Reverses Some Effects of Fatty Meals; Vitamin C and Blood Pressure

1-4-2009:    Secondhand Smoke & Heart Attack Risk; Poor Physical Fitness During Childhood & Heart Disease Risk During Adulthood

12-28-2008:  Stress & Your Risk of Heart Attack; Vitamin D & the Prevention of Colon & Rectal Polyps

12-21-2008:  Breast Cancer Incidence & Hormone Replacement Therapy; Circumcision & the Risk of HPV & HIV Infection

12-14-2008:  Vitamin E, Vitamin C and Selenium Do Not Prevent Cancer; Postscript: A Possible Cure for Down’s Syndrome

12-7-2008:    Generic vs. Brand-Name Drugs, Stress & Breast Cancer Survival

11-30-2008:  A Possible Cure for Down’s Syndrome?; Smoking & Cognitive Decline; Calcium & Vitamin D & Breast Cancer Risk

11-23-2008:   Breast Cancer & Fish Oil; Lymphedema after Breast Cancer Treatment; Vasectomy & Prostate Cancer Risk

11-16-2008:   Vitamin E & Vitamin C: No Impact on Cardiovascular Disease Risk; Does Lack of Sleep Increase Stroke & Heart Attack Risk in Hypertensive Patients?

11-9-2008:     Statins Cut Heart Attack Risk Even with Normal Cholesterol Levels; Statins & PSA Level

11-2-2008:     Radiation Treatment of Prostate Cancer & Second Cancers; Sexual Content on TV & Teen Pregnancy Risk

10-26-2008:   Smoking & Quality of Life

10-19-2008:   Agent Orange & Prostate Cancer

10-12-2008:   Pomegranate Juice & Prostate Cancer

10-5-2008:    Central Obesity & Dementia; Diet, Vitamin D, Calcium, & Colon Cancer

9-28-2008:    Publication & Citation Bias in Favor of Industry-Funded Research?

9-21-2008:    Does Tylenol® (Acetaminophen) Cause Asthma?

9-14-208:     Arthroscopic Knee Surgery- No Better than Placebo?; A Healthy Lifestyle Prevents Stroke

8-23-2008:   Alcohol Abuse Before & After Military Deployment; Running & Age; Running & Your Testicles

8-12-2008:   Green Tea & Diabetes; Breastfeeding & Adult Cholesterol Levels; Fish Oil & Senile Macular Degeneration

8-3-2008:    Exercise & Weight Loss; Green Tea, Folic Acid & Breast Cancer Risk; Foreign Language Interpreters & ICU Patients

 

7-26-2008:   Viagra & Sexual Function in Women; Patient-Reported Adverse Hospital Events; Curcumin & Pancreatic Cancer

7-13-2008:   Erectile Dysfunction & Frequency of Sex; Muscle Strength & Mortality in Men; Cryoablation for Prostate Cancer

7-6-2008:   Sleep, Melatonin & Breast Cancer Risk; Mediterranean Diet & Cancer Risk; New Treatment for Varicose Veins

6-29-2008:   Bone Marrow Stem Cells & Liver Failure; Vitamin D & Colorectal Cancer Survival; Green Tea & Colorectal Cancer

6-22-2008:   Obesity, Lifestyle & Heart Disease; Effects of Lifestyle & Nutrition on Prostate Cancer; Ginkgo Biloba, Ulcerative Colitis & Colorectal Cancer

6-15-2008:   Preventable Deaths after Coronary Artery Bypass Graft (CABG) Surgery; Green Tea & Colorectal Cancer; Attention-Deficit/Hyperactivity Disorder (ADHD) & St. John’s Wort

6-8-2008:   Vitamin D & Prostate Cancer Risk; Radiofrequency Ablation (RFA) of Kidney (Renal) Cancer; Antisense Telomerase & Cancer

6-2-2008:   Acute Coronary Syndrome- Do You Know the Symptoms?; Green Tea & Lung Cancer; Episiotomy & Subsequent Deliveries- An Unkind Cut

5-25-2008:   Early Childhood Screening Predicts Later Behavioral Problems; Psychiatric Disorders Among Parents of Autistic Children; Social & Psychiatric Profiles of Young Adults Born Prematurely

5-18-2008:   Can Statins Reverse Coronary Artery Disease?; Does Breast Ultrasound Improve Breast Cancer Detection?; Preventive Care Services at Veterans Administration (VA) Medical Centers

5-11-2008:   Smoking Cessation & Risk of Death; Childhood Traumas & Adult Suicide Risk; “White Coat Hypertension” & Risk of Cardiovascular Disease

5-4-2008:   Super-Size Me: Fast Food’s Effects on Your Liver; Exercise, Weight & Coronary Artery Disease; Contamination of Surgical Instruments in the Operating Room

4-27-2008:   Stents vs. Bypass Surgery for Coronary Artery Disease; The “DASH” Hypertension Diet & Cardiovascular Disease Prevention; Testosterone Therapy for Women with Decreased Sexual Desire & Function

4-20-2008:   BRCA Breast Cancer Mutations & MRI Scans; Bladder Cancer Prevention with Broccoli?; Diabetes: Risk of Death Due to Heart Attack & Stroke

4-13-2008:   Breast Cancer Recurrence & Hormone Replacement Therapy (HRT); Carotid Artery Disease: Surgery vs. Stents?; Statin Drugs & Cancer Prevention

4-6-2008:   Human Papilloma Virus (HPV), Pap Smear Results & Cervical Cancer; Human Papilloma Virus (HPV) Infection & Oral Cancer; Hormone Replacement Therapy (HRT) & the Risk of Gastroesophageal Reflux Disorder (GERD)

3-30-2008:   Abdominal Obesity & the Risk of Death in Women; Folic Acid Pretreatment & Heart Attacks; Pancreatic Cancer Regression after Injections of Bacteria

3-23-2008:   Age of Transfused Blood & Risk of Complications after Surgery; Obesity, Blood Pressure & Heart Size in Children

3-16-2008:   Benefits of a Full Drug Coverage Plan for Medicare Patients?; Parent-Teen Conversations about Sex; Soy (Genistein) & Prostate Cancer

3-9-2008:   Flat Colorectal Adenomas & Cancer; Health Risks after Stopping Hormone Replacement Therapy (HRT); Television, Children & Obesity 

3-2-2008:   Medication & Risk of Death After Heart Attack; Hormone Replacement Therapy (HRT) & Mammogram Results; Selenium: Cancer, Heart Disease & Death

2-23-2008:   Universal Healthcare Insurance Study; Glucosamine & Arthritis

2-17-2008:   Exceptional Longevity in Men; Testosterone & Risk of Prostate Cancer; Smoking & Pre-malignant Colorectal Polyps

2-10-2008:   Thrombus Aspiration from Coronary Arteries; Intensive Management of Diabetes & Death; Possible Cure for  Down's Syndrome?

2-3-2008:   Vitamin D & Cardiovascular Health; Vitamin D & Breast Cancer; Green Tea & Colorectal Cancer

1-27-2008:   Colorectal Cancer, Esophageal Cancer & Pancreatic Cancer: Update from the 2008 American Society of Clinical Oncology's Gastrointestinal Cancers Symposium

1-20-2008:   Testosterone Levels & Risk of Fractures in Elderly Men; Air Pollution & DNA Damage in Sperm; Statins & Trauma Survival in the Elderly

1-12-2008:   Statins, Diabetes & Stroke and Obesity; GERD & Esophageal Cancer

1-7-2008:   Testosterone Supplements in Elderly Men; Colorectal Cancer-- Reasons for Poor Compliance with Screening Recommendations

12-31-2007:   Minority Women, Hormone Replacement Therapy & Breast Cancer; Does Health Insurance Improve Health?

12-23-2007:  Is Coffee Safe After a Heart Attack?; Impact of Divorce on the Environment; Hypertension & the Risk of Dementia; Emotional Vitality & the Risk of Heart Disease

12-16-2007:   Honey vs. Dextromethorphan vs. No Treatment for Kids with Night-Time Cough, Acupuncture & Hot Flashes in Women with Breast Cancer, Physical Activity & the Risk of Death, Mediterranean Diet & Mortality  

12-11-2007:   Bias in Medical Research; Carbon Nanotubes & Radiofrequency: A New Weapon Against Cancer?; Childhood Obesity & Risk of Adult Heart Disease

12-2-2007:   Obesity & Risk of Cancer; Testosterone Level & Risk of Death; Drug Company Funding of Research & Results; Smoking & the Risk of Colon & Rectal Cancer 


Dr. Wascher's Home Page


Post a comment
Write a comment:

Related Searches